2019
DOI: 10.1097/md.0000000000016703
|View full text |Cite
|
Sign up to set email alerts
|

Safety issues related to the electronic cross-matching of blood in mainland China

Abstract: Supplemental Digital Content is available in the text

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 10 publications
0
2
0
Order By: Relevance
“…While all centers follow the same general recommendations, the timing is different. To be eligible for EXM, the patient must have at least two separate blood samples where ABO/Rh tests were performed, a negative antibody screen, and no previously positive antibody screening test [31][32][33]. Patients with confirmed or suspected red cell alloantibodies, newborns, and recipients of ABO-incompatible hematopoietic stem cells are excluded from EXM [31][32][33].…”
Section: Plos Onementioning
confidence: 99%
See 1 more Smart Citation
“…While all centers follow the same general recommendations, the timing is different. To be eligible for EXM, the patient must have at least two separate blood samples where ABO/Rh tests were performed, a negative antibody screen, and no previously positive antibody screening test [31][32][33]. Patients with confirmed or suspected red cell alloantibodies, newborns, and recipients of ABO-incompatible hematopoietic stem cells are excluded from EXM [31][32][33].…”
Section: Plos Onementioning
confidence: 99%
“…It was found to reduce the workload in the lab, the number of blood components transferred to the ward, and the number of unused units [30,31]. Compared to standard serological crossmatching, EXM offers several advantages, including a short processing time, low cost, and ease of use [32]. Surgeons believe that the advantages include promptness and a practically limitless supply of blood.…”
Section: Plos Onementioning
confidence: 99%